Tumour architecture is an independent predictor of outcomes after nephroureterectomy: A multi-institutional analysis of 1363 patients

BJU International

Volumn 103, Issue 3, 2009, Pages 307-311

  Remzi, Mesut ^a   Haitel, Andrea ^a   Margulis, Vitaly ^b   Karakiewizc, Pierre ^c   Montorsi, Francesco ^d   Kikuchi, Eiji ^e   Zigeuner, Richard ^f   Weizer, Alon ^g   Bolenz, Christian ^h   Bensalah, Karim ⁱ   Suardi, Nazareno ^c   Raman, Jay D ^j   Lotan, Yair ^k   Waldert, Matthias ^a   Ng, Casey K ^j   Fernández, Mario ^l   Koppie, Theresa M ^m   Ströbel, Philipp ^h   Kabbani, Wareef ^k   Murai, Masaru ^e   Langner, Cord ^f   Roscigno, Marco ^d   Wheat, Jeffrey ^g   Guo, Charles C ^b   Wood, Christopher G ^b   Shariat, Shahrokh F ^k,n   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g UNIVERSITY OF MICHIGAN   (United States)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ UNIVERSITÉ DE RENNES 1   (France)

^j Department of Obstetrics Gynecology   (United States)

^k UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^l UNIVERSIDAD DEL DESARROLLO   (Chile)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

Architecture; Recurrence; Survival; Urinary tract cancer; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; URETER; UROLOGIC NEOPLASMS;

EID: 58449118569     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08003.x     Document Type: Article

References (12)

1. Guinan P, Vogelzang NJ, Randazzo R et al. Renal pelvic cancer: a review of 611 patients treated in Illinois 1975-85. Cancer Incidence and End Results Committee. Urology 1992 40 : 393 9
2. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998 52 : 594 601
3. Remzi M, Müller L, Klingler HC et al. Mid-term follow up (5 years) of laparoscopic nephroureterectomy compared to open nephroureterectomy for upper urinary tract transitional cell cancer. Eur Urol Suppl 2007 6 : A794
4. Novara G, De Marco V, Gottardo F et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 2007 110 : 1715 22
5. Tosoni I, Wagner U, Sauter G et al. Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. BJU Int 2000 85 : 48 53
6. Bol MG, Baak JP, Buhr-Wildhagen S et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 2003 169 : 1291 4
7. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder. Am J Surg Pathol 1998 22 : 1435 48
8. Harrell FE Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA 1982 247 : 2543 6
9. Harrell FE Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996 15 : 361 87
10. Krüger S, Noack F, Böhle A, Feller AC. Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder. Oncol Rep 2004 12 : 609 13
11. Langner C, Hutterer G, Chromecki T, Rehak P, Zigeuner R. Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Arch 2006 448 : 604 11
12. Jimenez RE, Gheiler E, Oskanian P et al. Grading the incasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 2000 24 : 980 7